Searched for
MENA LABORATORIES
Smartkarma Research: APAC Healthcare Series - Top picks are poised for multi-year growthGland Pharma’s near-term focus remains on establishing a strong portfolio of complex injectables. The company is working on development of ...03 Mar, 2022, 01.02 PM IST- Stocks in the news: Max Financial, Vodafone Idea, Simplex Infra, Axis Bank and Power GridGlobal investors are in discussions with Tata Power to invest $500-600 million in its renewable energy platform.20 Feb, 2020, 09.23 AM IST
- Analysts bullish on Dabur despite fall in operating marginsAnalysts are bullish on the stock despite a fall in operating margins due to the high topline growth and an expected margin improvement in ...06 Feb, 2012, 08.00 AM IST
- Metropolis, SRL scout for buys in South AfricaCompanies in talks with pathology chains.21 Oct, 2010, 03.28 AM IST
- SRL to acquire Piramal arm for Rs 600 crThe deal makes the Delhi-based co country’s largest diagnostic player with 170 labs & 1,500 collection centres.14 Jul, 2010, 01.59 AM IST
- SRL in talks to acquire Piramal DiagnosticsDiagnostic chain Super Religare Laboratories is in advanced talks to buy Piramal Healthcare’s diagnostic chain for up to Rs 800 crore.12 Jul, 2010, 06.44 AM IST
- Diagnostic chains scout for standalone regional buyoutsDiagnostic chains such as Dr Lal Pathlabs, Super Religare Laboratories, Piramal Diagnostics and Metropolis are scouting for regional diagno...08 Mar, 2010, 02.38 AM IST
- Super Religare plans to mop up Rs 200 crDiagnostic chain Super Religare Laboratories (formerly SRL Ranbaxy) is reviving plans to dilute 15-20% stake to raise Rs 200 crore through ...03 Nov, 2009, 12.29 AM IST
Load More
